Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will present five abstracts at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting taking place November 19-23 in Honolulu ...

Jazz Pharmaceuticals plc  today announced that the company will present five abstracts at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting taking place November 19-23 in Honolulu, Hawaii. The ...

The Speaker of Parliament, Alban Bagbin, has formally apologised to the Judiciary for the heated exchanges that marred the ...

Fabhalta and Vanrafia Phase III analyses, Fabhalta real-world treatment pattern data, and zigakibart Phase I/II trial showcase strength of IgA nephropathy (IgAN) portfolioC3 glomerulopathy (C3G) studi ...

Successful catheter ablation resulted in a low risk of stroke associated with atrial fibrillation (AFib), a type of irregular ...

In a recent study on patients with colon cancer, participants given an exercise program lived longer than the group that ...

SITC abstracts highlight updated immunogenicity results from the Phase 2 AMPLIFY-7P trial of ELI-002 7P and preclinical data on the use of ...

Q3 2025 Earnings Call Transcript October 28, 2025 Operator: Thank you for standing by. Welcome to the Kiniksa Pharmaceuticals ...

FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Phase 1/2 Trial in Diabetic Foot Ulcers to Initiate in 1Q26 ...

The National Health Insurance Authority on Thursday announced that its enrolment portal has been restored and is now fully ...

Q3 2025 Earnings Call November 6, 2025 8:00 AM ESTCompany ParticipantsAndrew Barnett - Head of Investor RelationsPascal Soriot - ...

Obesity and cancer are two major health challenges of our time, yet the link between them remains only partially understood. New research now ...